1.more than 10 years manufacture history
2.High efficiency,low toxicity and low residue
3.High quanlity and moderate
4.GMP
Pharmacological properites:
Dexamethasone is a very potent synthetic glucocorticosteroid, its anti-inflammatory effects being 30 times stronger than those of cortisone and 7-10 times stronger than those of pridnisolone. In addition to its antiphlogistic properties, dexamethasone also shows extraordinary anti-allergic, anti-stress and gluconeogenetic activities. Mineralcorticoid activity is minimal.
Indication:
Metabolic disorders such as: ketosis in cattle and puerperal toxaemia in ewes and sows. |
Non-infectious inflammatory processes, especially acute musculoskeletal inflammations such as: arthritis, periarthritis, tendovaginitis, bursitis, luxations, myositis, osselets and sprains. |
As an aid in acute infectious diseases (e.g. acute mastitis, metritis, pneumonia, polyarthritis in calves) in combination with suitable anti-infectious therapy. |
allergic conditions, e.g. asthma, allergic skin affections (eczema, urticaria,pruritis, ), laminitis in horses and cattle, snake-bites. |
Stress-and shock conditions |
Induction of parturition in ruminants during the last stage of pregnancy ( delivery within 2-4 days). |
Dosage and administration:
By intravenous, intramuscular or subcutaneous (dogs, cats) injection:
Cats, dogs: | (0.1-0.2 mg/kg b.w.) 0.25-0.5 ml/5 kg |
Cattle, horses: | (2.5-5 mg/100 kg b.w.) 5-10 ml/400 kg |
Sheep, goats, calves: | (2-4 mg/50 kg ) 1-2 ml/50 kg |
If necessary repeat with 2 days intervals in dogs and cats and 3-4 days intervals in other animals.
--For induction of parturition in cows (given within 1 week before expected calving date): (5 mg/100 kg b.w.) 2.5 ml/100kg
--Puerperal toxaemia and induction of parturition in sheep and goats: (2.5 mg/10 kg b.w.) 6 ml/50 kg
--Shock-therapy: by slow I.V. injection of high doses(10*), eventually to be repeated after 8-12h.
By intraarticular injection: according to the extension of joint and animal weight: 0.25 to 4 ml.
Store Name:Hebei Guangren Pharmaceutical Technology CO.,LTD.
Phone:+86 13933828095
E-mail:[email protected]